– Biogen Inc said on Monday its research chief Alfred Sandrock, who led development of its Alzheimer’s disease drug Aduhelm, is leaving the company after a 23-year run. The company …
Shore News Network is a free website that does not use paywalls or charge for access to original, breaking news content. In order to provide this free service, we rely on advertisements. Please support our journalism by disabling your ad blocker for this website.